Table 1 Demographic and clinicopathological characteristics of endometrial cancer patients who underwent robotic surgical staging using da Vinci SP (n = 42) or Xi system (n = 126).
SP (n = 42) | Xi (n = 126) | p-value | |
|---|---|---|---|
Age, years, Mean ± SD | 48.7 ± 8.8 | 48.6 ± 8.7 | 0.927 |
Body mass index, kg/m2, Mean ± SD | 24.4 ± 4.7 | 25.3 ± 5.1 | 0.274 |
Gravidity, Median (IQR) | 2 (1–3) | 2 (1–3) | 0.734 |
Parity, Median (IQR) | 2 (0–2) | 2 (0–2) | 0.683 |
Menopause, n (%) | 18 (42.8) | 41 (32.5) | 0.225 |
Previous abdominal surgery, n (%) | 14 (33.3) | 34 (27.0) | 0.430 |
ASA class, n (%) | 0.979 | ||
I | 7 (16.7) | 22 (17.5) | |
II | 31 (73.8) | 91 (72.2) | |
III | 4(9.5) | 13 (10.3) | |
FIGO stage, n (%) | 0.708 | ||
I | 38 (90.4) | 110 (87.3) | |
II | 2 (4.8) | 4 (3.2) | |
III | 2 (4.8) | 11 (8.7) | |
IV | 0 | 1 (0.8) | |
Histologic type, n (%) | |||
Endometrioid adenocarcinoma | 42 (100) | 126 (100) | |
Others | 0 | 0 | |
Grade, n (%) | 0.576 | ||
G1 | 25 (59.5) | 67 (53.2) | |
G2 | 13 (31.0) | 50 (39.7) | |
G3 | 4 (9.5) | 9 (7.1) | |
Myometrial invasion, n (%) | 0.611 | ||
< 1/2 | 37 (88.1) | 107 (84.9) | |
≥ 1/2 | 5 (11.9) | 19 (15.1) | |
Lymphovascular space invasion, n (%) | 1 (2.4) | 20 (15.9) | 0.022 |
Uterus weight, g, Mean ± SD | 157.1 ± 68.3 | 149.8 ± 111.8 | 0.691 |
Abdominal adhesion, n (%) | 21 (50.0) | 38 (30.2) | 0.020 |
Postoperative treatment | |||
CTx, n (%) | 4 (9.5) | 7 (5.6) | |
T + C | 3 (7.1) | 6 (4.8) | |
Other regimen | 1 (2.4) | 1 (0.8) | |
Total cycle, median (range) | 5 (4–6) | 6 (3–6) | |
RTx, n (%) | 3 (7.1) | 24 (19.0) | |
Vaginal | 2 (4.8) | 22 (17.5) | |
Whole pelvis + Vaginal | 1 (2.4) | 2 (1.6) | |
CTx + RTx, n (%) | 1 (2.4) | 7 (5.6) | |
